3 Critical Near-Term Milestones to Watch With Pfizer's Coronavirus Vaccine

3 Critical Near-Term Milestones to Watch With Pfizer's Coronavirus Vaccine
3 Critical Near-Term Milestones to Watch With Pfizer's Coronavirus Vaccine
Keith Speights, The Motley Fool

Which coronavirus vaccine candidate is the one to closely monitor right now? There's a good case to be made that it's BNT162b2, which was developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX). Here are three critical near-term milestones to watch with Pfizer's coronavirus vaccine.